Teladoc Health Files Q3 2024 10-Q
Ticker: TDOC · Form: 10-Q · Filed: Oct 31, 2024 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | 10-Q |
| Filed Date | Oct 31, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, healthcare
Related Tickers: TDOC
TL;DR
TDOC Q3 2024 10-Q filed. Financials and operations update.
AI Summary
Teladoc Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the telehealth sector.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for Teladoc Health, crucial for understanding the company's current health and future prospects in the competitive telehealth market.
Risk Assessment
Risk Level: medium — The company operates in a dynamic and competitive healthcare technology sector, facing risks related to market adoption, regulatory changes, and competition.
Key Players & Entities
- Teladoc Health, Inc. (company) — Filer of the 10-Q report
- 2024-09-30 (date) — End of the reporting period
- 2024-10-31 (date) — Date the filing was made
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the period ending September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on October 31, 2024.
What is the company's primary business as indicated by the SIC code?
The company's primary business is indicated by SIC code 8011, which falls under SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE.
What is the state of incorporation for Teladoc Health, Inc.?
Teladoc Health, Inc. is incorporated in Delaware (DE).
What was the former name of Teladoc Health, Inc. and when did the name change occur?
The former name was Teladoc, Inc., and the name change occurred on November 23, 2009.
Filing Stats: 4,562 words · 18 min read · ~15 pages · Grade level 16.7 · Accepted 2024-10-31 10:20:04
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share TDOC New York Stock Exchange
Filing Documents
- tdoc-20240930.htm (10-Q) — 1327KB
- tdoc-20240930xexx101.htm (EX-10.1) — 113KB
- tdoc-20240930xexx311.htm (EX-31.1) — 10KB
- tdoc-20240930xexx312.htm (EX-31.2) — 10KB
- tdoc-20240930xexx321.htm (EX-32.1) — 4KB
- tdoc-20240930xexx322.htm (EX-32.2) — 4KB
- 0001477449-24-000225.txt ( ) — 7871KB
- tdoc-20240930.xsd (EX-101.SCH) — 58KB
- tdoc-20240930_cal.xml (EX-101.CAL) — 87KB
- tdoc-20240930_def.xml (EX-101.DEF) — 240KB
- tdoc-20240930_lab.xml (EX-101.LAB) — 674KB
- tdoc-20240930_pre.xml (EX-101.PRE) — 494KB
- tdoc-20240930_htm.xml (XML) — 1150KB
Financial Statements
Financial Statements 2 Condensed Consolidated Balance Sheets as of September 30, 2024 (unaudited) and December 31, 2023 2 Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) for the three and nine months ended September 30, 2024 and 2023 3 Condensed Consolidated Statements of Stockholders' Equity (unaudited) for the three and nine months ended September 30, 2024 and 2023 4 Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2024 and 2023 5 Notes to Unaudited Condensed Consolidated Financial Statements 6 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 37 Item 4.
Controls and Procedures
Controls and Procedures 38 PART II Other Information 39 Item 1.
Legal Proceedings
Legal Proceedings 39 Item 1A.
Risk Factors
Risk Factors 39 Item 5. Other Information 40 Item 6. Exhibits 40 Exhibit Index 40
Signatures
Signatures 42 1 Table of Contents PART I FINANCIAL INFORMATION
Financial Statements
ITEM 1. Financial Statements TELADOC HEALTH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data, unaudited) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 1,243,866 $ 1,123,675 Accounts receivable, net of allowance for doubtful accounts of $ 4,318 and $ 4,240 at September 30, 2024 and December 31, 2023, respectively 212,039 217,423 Inventories 36,993 29,513 Prepaid expenses and other current assets 115,738 118,437 Total current assets 1,608,636 1,489,048 Property and equipment, net 28,030 32,032 Goodwill 283,190 1,073,190 Intangible assets, net 1,496,698 1,677,781 Operating lease—right-of-use assets 34,115 40,060 Other assets 77,912 80,258 Total assets $ 3,528,581 $ 4,392,369 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 37,801 $ 43,637 Accrued expenses and other current liabilities 188,095 178,634 Accrued compensation 66,437 102,686 Deferred revenue—current 88,325 95,659 Convertible senior notes, net—current 550,723 — Total current liabilities 931,381 420,616 Other liabilities 736 1,080 Operating lease liabilities, net of current portion 36,896 42,837 Deferred revenue, net of current portion 10,469 13,623 Deferred taxes, net 50,846 49,452 Convertible senior notes, net—non-current 990,551 1,538,688 Total liabilities 2,020,879 2,066,296 Commitments and contingencies (Note 14) Stockholders' equity: Common stock, $ 0.001 par value; 300,000,000 shares authorized; 171,944,014 shares and 166,658,253 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 172 167 Additional paid-in capital 17,726,127 17,591,551 Accumulated deficit ( 16,181,491 ) ( 15,228,655 ) Accumulated other comprehensive loss ( 37,106 ) ( 36,990 ) Total stockholders' equity 1,507,702 2,326,073 Total liabilities and stockholders' equity $ 3,528,581 $ 4,392,369 See accompanying notes to unaudited condensed consolidat